[ Price : $8.95]
The National Institutes of Health awards $29 million to fund five additional Research Evaluation and Commercialization Hubs to spe...[ Price : $8.95]
FDA accepts for priority review a Merck NDA for Dificid (fidaxomicin) for oral suspension, and a supplemental NDA for a new indica...[ Price : $8.95]
FDA approves a Puma Biotechnology labeling supplement for Nerlynx (neratinib) for the extended adjuvant treatment of HER2-positive...[ Price : $8.95]
Federal Register notice: FDA determines that 24 drug products were not withdrawn due to safety or effectiveness reasons.[ Price : $8.95]
Federal Register notice: FDA announces an 11/13-14 Immunology Devices Panel of the Medical Devices Advisory Committee meeting to d...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on Patient-Focused Drug Development: Methods To Identify What Is Imp...[ Price : $8.95]
FDA warns South Koreas Dermameal about CGMP violations in its role as a contract manufacturer of finished pharmaceuticals.[ Price : $8.95]
FDA awards a five-year contract that could be worth $220 million to Harvard Pilgrim Health Care Institute for the next phase of th...